ArticleImmunity, inflammation and disease2026
Can Blood Cell Count-Based Inflammatory Markers Reflect the Risk of Osteoporosis? A Cross-Sectional and Genetic Analysis.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Can Blood Cell Count-Based Inflammatory Markers Reflect the Risk of Osteoporosis? A Cross-Sectional and Genetic Analysis.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundOsteoporosis (OP) is characterized by reduced bone mineral density and bone structural deterioration, with a growing global prevalence. This study aims to explore the relationship between systemic inflammatory markers (SII, SIRI, AISI) and OP risk, and to assess their causal effects using genetic methods.
methodsA cross-sectional analysis was conducted using data from 8,070 eligible participants. The relationships between SII, SIRI, AISI, bone mineral density, and OP risk were assessed through weighted multivariable regression and smooth curve fitting. Subgroup analyses examined the moderating effects of factors such as BMI and alcohol consumption. Mendelian randomization analysis was also performed using GWAS data to explore the causal relationship between blood cell counts and OP.
resultsElevated levels of SII, SIRI, and AISI were significantly associated with decreased bone mineral density and increased OP risk, with these associations remaining significant after adjusting for various confounders. Subgroup analyses revealed that the association between SII and OP was more pronounced in individuals with low BMI and those who consumed alcohol. Genetic analysis further provided evidence supporting that higher levels of specific blood cells, such as platelets and eosinophils, serve as causal factors contributing to increased OP risk.
conclusionsThis study demonstrates that SII, SIRI, and AISI, as reliable indicators of systemic inflammation, can effectively predict OP risk, particularly in populations with low BMI and those who consume alcohol. These inflammatory markers may serve as tools for early OP screening and offer new insights for personalized prevention and intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.